| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ade8fab64fcd515ff995e111f598756 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_687a2ae178d9b0753beffb7237ff3c8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2aad5a9a226d4f1bd6bcbe03032a0e |
| publicationDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110545844-A |
| titleOfInvention |
Cancer treatment using antibodies that bind cytotoxic T lymphocyte antigen-4 (CTLA-4) |
| abstract |
Among other things, the present application provides antibodies or antigen-binding fragments thereof that target CTLA-4 expressed on damaged tissues associated with various diseases. These anti-CTLA-4 antibodies or antigen-binding fragments thereof have high affinity for CTLA-4 and function to inhibit CTLA-4. The antibodies and antigen-binding fragments are useful in the treatment of human diseases, infections and other conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023134771-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113244389-A |
| priorityDate |
2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |